FDA Inspection 704480 — Concordia Clinical Research (IRB)

Concordia Clinical Research (IRB) — FEI 2245239

The FDA completed an inspection of Concordia Clinical Research (IRB) on Dec 30, 2010 in Cedar Knolls, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 8 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 30, 2010
Fiscal Year
2011
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cedar Knolls, NJ (United States)

Additional details

IRB

Citations

IDCFRDescription
727821 CFR 56.107(e)Conflict of interest
728121 CFR 56.108(a)(1)Initial and continuing reviews
731721 CFR 56.115(a)(1)Copies of all research proposals and related documents
731821 CFR 56.115(a)(2)Minutes of IRB meetings
731921 CFR 56.115(a)(3)Records of continuing review
732021 CFR 56.109(e)IRB approvals/disapprovals - general
739021 CFR 50.25(a)(4)Alternate procedures, courses of treatment
739321 CFR 50.25(a)(8)Participation; refusal and discontinuance

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.